Transl Res. 2010 Feb; 155(2) : 62-70. Epub 2009 Aug 6. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson’s disease. Venkataramana NK, Kumar SK, Balaraju S, Radhakrishnan RC, Bansal A, Dixit A, Rao DK, Das M, Jan M, Gupta PK, Totey SM. Advanced Neuroscience Institute, BGS-Global Hospital, Bangalore, India. drnkvr@gmail.com Comment…

Neurosci Bull. 2010 Feb; 26(1) : 66-76. Treatment strategies for Parkinson’s disease. Yuan H, Zhang ZW, Liang LW, Shen Q, Wang XD, Ren SM, Ma HJ, Jiao SJ, Liu P. Department of Integrated Traditional Chinese and Western Medicine, the General Hospital of Chinese People’s Armed Police Forces , Beijing 100039, China. blsphd2005@126.com Abstract Parkinson’s disease…

J Clin Invest. 2010 Jan 4; 120(1) : 51-9. doi: 10.1172/JCI40553. Progress toward the clinical application of patient-specific pluripotent stem cells. Kiskinis E, Eggan K. The Stowers Medical Institute, Harvard Stem Cell Institute, Department of Stem Cell and Regenerative Biology, Harvard University, 7 Divinity Avenue, Cambridge, MA 02138, USA. ekiskinis@mcb.harvard.edu Abstract Induced pluripotent stem (iPS)…

Curr Neurovasc Res. 2010 Feb 1; 7(1) : 49-58. Human tooth germ stem cells preserve neuro-protective effects after long-term cryo-preservation. Yalvaç ME, Ramazanoglu M, Tekguc M, Bayrak OF, Shafigullina AK, Salafutdinov II, Blatt NL, Kiyasov AP, Sahin F, Palotás A, Rizvanov AA. Department of Genetics and BioEngineering, College of Engineering and Architecture, Yeditepe University, Campus,…

Adv G erontol. 2009; 22(1) : 150-66. Cell therapy for Parkinson’s disease: II. Somatic stem cell-based applications- [Article in Russian] Anisimov SV. Abstract Motor dysfunctions in Parkinson’s disease are believed to be primarily due to the degeneration of dopaminergic neurons located in the substantia nigra pars compacta. Numerous cell replacement therapy approaches have been developed…

Stem Cells Dev. 2010 Jul; 19(7) : 1017-23. Cell therapy for Parkinson’s disease: II. Somatic stem cell-based applications- Cai J, Yang M, Poremsky E, Kidd S, Schneider JS, Iacovitti L. Farber Institute for Neurosciences, Department of Neurology, Thomas Jefferson University , Philadelphia, PA 19107, USA. Abstract Cell replacement therapy could be an important treatment strategy…

Indian J Med Res. 2010 Apr; 131 : 536-44. Transplantation of retinoic acid treated murine embryonic stem cells & behavioural deficit in Parkinsonian rats. Fathi F, Altiraihi T, Mowla SJ, Movahedin M. Kurdistan Center for Cellular & Molecular Research, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj,Tarbiat Modarres University, Tehran, Iran. farfath@yahoo.com Abstract BACKGROUND…

Regen Med. 2010 Mar; 5(2) : 267-78. Stem cell-derived dopamine neurons for brain repair in Parkinson’s disease. Fricker-Gates RA, Gates MA. Keele University, Keele, Staffordshire, UK. r.a.fricker-gates@hfac.keele.ac.uk Abstract One of the prospects for a curative treatment for Parkinson’s disease is to replace the lost dopaminergic neurons. Preclinical and clinical trials have demonstrated that dissected fetal…

IDrugs. 2010 Feb; 13(2) : 82-4. Parkinson’s disease and related disorders–XVIII WFN World Congress. Grosset D. Southern General Hospital, 1345 Govan Road, Glasgow, G51 4TF, UK. d.grosset@clinmed.gla.ac.uk Abstract The XVIII World Federation of Neurology (WFN) World Congress on Parkinson’s Disease and Related Disorders, held in Miami, FL, USA, included topics covering new therapeutic developments in…

Curr Med Chem. 2010; 17(8) : 759-66. Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery. Gunaseeli I, Doss MX, Antzelevitch C, Hescheler J, Sachinidis A. Center of Physiology and Pathophysiology, Institute of Neurophysiology, and Center of Molecular Medicine, University of Cologne (CMMC), Robert-Koch Str. 39, Cologne, Germany. Abstract Human…